Vertical: CNMBase Year: 2025
Market Size (2025)
$19.20M
Projected (2032)
$29.77M
CAGR (2022–2032)
6.5%
Key Players
7+
Market Overview
The global 2-Chloro-5-Chloromethylpyridine (CCMP) market was valued at USD 19.202 Million in 2025 and is projected to reach USD 29.765 Million by 2032, registering a CAGR of 6.45% over 2026–2032. In absolute terms, the market is expected to add USD 10.563 Million between 2025 and 2032. Historically, the market expanded from USD 15.854 Million in 2022 to USD 18.019 Million in 2024, supported by steady consumption of CCMP as the principal pyridine building block for the neonicotinoid insecticides imidacloprid and acetamiprid.
CCMP (CAS No. 70258-18-3) is a chlorinated pyridine intermediate that supplies the 6-chloro-3-pyridylmethyl moiety common to the first-generation chloronicotinyl insecticides. Because demand for the intermediate is derived almost entirely from technical-grade insecticide production, the market is shaped by crop protection consumption patterns, the regulatory status of neonicotinoids in major agricultural economies, and the industrial organisation of pyridine and agrochemical manufacturing, which is concentrated in China and, increasingly, India.
Key Findings
By downstream product: Imidacloprid is the largest segment, accounting for 55.0% of the market in 2025 (USD 10.561 Million), while Acetamiprid is the fastest-growing segment, with a CAGR of 7.52% over 2026–2032.
By purity: The 98% & Above grade is the largest segment with a 80.0% share in 2025 (USD 15.362 Million) and is also the fastest-growing segment, at a CAGR of 6.92%.
By region: Asia Pacific is the leading region, accounting for 78.0% of global value in 2025 (USD 14.978 Million). Latin America is the fastest-growing region, with a CAGR of 7.67%.
By country: China is the leading country market, valued at USD 8.687 Million in 2025, while Saudi Arabia is the fastest-growing country, with a CAGR of 8.15% over 2026–2032.
Segmentation Summary
By downstream product, the market is segmented into Imidacloprid, Acetamiprid and Others. Imidacloprid remains the anchor application, valued at USD 10.561 Million in 2025 and projected to reach USD 15.518 Million by 2032 at a CAGR of 5.65%. Acetamiprid, valued at USD 5.761 Million in 2025, is projected to grow faster at 7.52%, reflecting its more favourable regulatory standing in several markets. The Others segment, which covers additional CCMP-derived actives such as thiacloprid and nitenpyram, is projected to grow at 7.07%.
By purity, the market is divided into 98% & Above and Below 98%. High-purity material accounted for USD 15.362 Million in 2025 and is projected to reach USD 24.570 Million by 2032 (CAGR 6.92%), as technical-grade producers seek higher yields and tighter impurity profiles. The Below 98% grade, valued at USD 3.840 Million in 2025, is projected to grow at a slower 4.41%.
Competitive Landscape Summary
The CCMP market is moderately consolidated and is dominated by vertically integrated Chinese agrochemical producers that manufacture CCMP largely for captive conversion into imidacloprid and acetamiprid technical. Leading participants include Hailir Pesticides and Chemicals Group, Shandong Sino-Agri Union Biotechnology, Jiangsu Changqing Agrochemical, Nanjing Red Sun, Jiangsu Yangnong Chemical, Jiangsu Kesheng Group and Hebei Yetian Agrochemical, alongside India's Jubilant Ingrevia, a major producer of pyridine and picoline feedstocks. Competition centres on cost position, feedstock integration, environmental compliance and product purity, with relatively little volume traded on the open merchant market.
Challenges and Opportunities
The principal challenge facing the market is regulatory pressure on neonicotinoids. The European Union restricted the outdoor use of imidacloprid, clothianidin and thiamethoxam in 2018, lowered maximum residue levels (MRLs) for clothianidin and thiamethoxam through Regulation (EU) 2023/334, and lowered a range of acetamiprid MRLs through Regulation (EU) 2025/158. Canada, Brazil and the United States have also re-evaluated neonicotinoid uses. Environmental and safety enforcement in Chinese chemical parks adds compliance cost to chlorination-intensive processes.
Opportunities arise from rising crop protection demand in Latin America, South and Southeast Asia and the Middle East and Africa, the continued shift toward acetamiprid, investment in cleaner and higher-yield synthesis routes, and supply-chain diversification that is supporting new pyridine-chain capacity in India.
Future Outlook
Over the forecast period, the market is expected to grow steadily from USD 20.459 Million in 2026 to USD 29.765 Million in 2032. Growth will be led by Asia Pacific, which is projected to reach USD 23.368 Million by 2032, and by the faster-expanding Latin America and Middle East & Africa regions. Product mix is expected to tilt gradually toward acetamiprid and high-purity grades, while producers that combine integrated pyridine feedstock, efficient chlorination technology and strong environmental performance are expected to strengthen their positions.
The 2-Chloro-5-Chloromethylpyridine Market market is projected to grow at a CAGR of 6.5% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
2-Chloro-5-Chloromethylpyridine (CCMP; molecular formula C6H5Cl2N; CAS No. 70258-18-3) is a dichlorinated pyridine derivative in which a chlorine atom occupies the 2-position of the pyridine ring and a chloromethyl group occupies the 5-position. It is a low-melting crystalline solid at ambient conditions. The reactive chloromethyl group allows CCMP to alkylate nitrogen nucleophiles, which makes it the standard building block for introducing the 6-chloro-3-pyridylmethyl group into chloronicotinyl insecticides.
Commercially, CCMP is produced by two principal route families: the cyclopentadiene–acrolein route, which builds the pyridine ring and dominates Chinese production for imidacloprid, and routes based on the chlorination of 3-methylpyridine (beta-picoline) through 2-chloro-5-methylpyridine. In downstream use, CCMP is condensed with 2-nitroiminoimidazolidine to produce imidacloprid, and with methylamine followed by an N-cyanoacetamidine-forming step to produce acetamiprid. It is also used in the synthesis of other neonicotinoid actives such as thiacloprid and nitenpyram.
Included in the scope: CCMP produced and consumed for the manufacture of imidacloprid, acetamiprid and other CCMP-derived active ingredients, covering both merchant sales and material transferred for captive conversion, across the 98% & Above and Below 98% purity grades.
Excluded from the scope: pyridine bases and picolines sold as such; other chloropyridine intermediates such as 2-chloro-5-methylpyridine (when not converted to CCMP), 2,3-dichloropyridine and trifluoromethylpyridines; neonicotinoids that do not use CCMP (such as thiamethoxam, clothianidin and dinotefuran, which are based on chlorothiazole or tetrahydrofuran moieties); and the value of downstream technical-grade actives and formulated products.
Scope of the Study
The study covers the global CCMP market across the following segmentations, which are reproduced exactly as defined in the underlying market data:
By Downstream Product: Imidacloprid, Acetamiprid, Others
By Purity: 98% & Above, Below 98%
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, with country-level coverage within each region
The study timeline comprises historic years 2022, 2023 and 2024, the base year 2025, and the forecast period 2026–2032. All market values are expressed in USD Million, and growth rates are presented as the compound annual growth rate (CAGR) for 2026–2032.
Research Objectives
To estimate and forecast the size of the global CCMP market in value terms (USD Million) for 2022–2032.
To analyse the market by downstream product (Imidacloprid, Acetamiprid, Others) and by purity (98% & Above, Below 98%), identifying the largest and fastest-growing segments.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
To evaluate the drivers, restraints, opportunities, trends and challenges shaping demand for CCMP, with particular attention to neonicotinoid regulation.
To map the CCMP value chain from pyridine and chlorine feedstocks through technical-grade insecticide production to end use.
To examine the regulatory landscape governing CCMP manufacture, trade and downstream neonicotinoid registration in major regions.
To profile the competitive structure of the market, including the positioning and strategic developments of leading producers since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process that combines secondary research, primary research with industry participants, and quantitative modelling. The process begins with defining the market and its segmentation, followed by data collection on production, consumption and pricing of CCMP and its downstream insecticides. Market estimates are developed with both top-down and bottom-up approaches, reconciled through data triangulation, and then validated with industry experts before final forecasting.
Market definition and scoping: product boundaries, segmentation and geographic coverage.
Secondary data collection: company disclosures, regulatory databases, trade statistics and technical literature.
Primary validation: interviews with supply-side and demand-side participants.
Market estimation and triangulation: top-down and bottom-up sizing reconciled across data sources.
Forecasting and review: projection of segment, regional and country values for 2026–2032 and final quality review.
Secondary Research
Secondary research established the baseline understanding of the CCMP value chain, production technology, demand patterns and regulation. Sources relevant to this industry include:
Industry associations: China Crop Protection Industry Association (CCPIA), CropLife International and its regional associations, Crop Care Federation of India and Pesticide Manufacturers & Formulators Association of India.
Government and regulatory bodies: US Environmental Protection Agency (EPA), European Commission and European Food Safety Authority (EFSA), European Chemicals Agency (ECHA), Health Canada Pest Management Regulatory Agency (PMRA), China Institute for the Control of Agrochemicals (ICAMA), India Central Insecticides Board & Registration Committee (CIB&RC) and Brazil IBAMA.
Company filings: annual reports, interim reports, environmental impact assessments and stock exchange disclosures of listed pyridine and agrochemical producers.
Trade journals and technical literature: agrochemical trade press, patent literature on CCMP synthesis, and peer-reviewed chemistry and process engineering journals.
Trade and statistical databases: UN Comtrade and national customs data for heterocyclic nitrogen compounds and insecticide technicals, FAOSTAT pesticide use statistics, and paid chemical and agrochemical market databases.
Primary Research
Primary research was conducted to validate secondary findings, refine market estimates and capture qualitative insight into competitive dynamics. Interviews were held with participants on both the supply side and the demand side of the market.
Supply-side respondents: CCMP and pyridine-base manufacturers, technical-grade imidacloprid and acetamiprid producers, process technology providers, and chemical traders and distributors.
Demand-side respondents: procurement and technical managers at agrochemical formulation companies, crop protection distributors, and agronomy and regulatory specialists.
Objectives: to validate capacity, utilisation and pricing assumptions; to understand captive versus merchant supply; to assess purity requirements by downstream product; and to gauge the impact of regulatory developments on demand.
Market Size Estimation
Top-down approach: The global crop protection and insecticide markets were used as the starting point. The share of neonicotinoid insecticides, and within that the share of imidacloprid, acetamiprid and other CCMP-derived actives, was estimated. Technical-grade active ingredient volumes were then converted into CCMP requirements using stoichiometric consumption ratios and process yields, and valued at prevailing CCMP prices.
Bottom-up approach: Production capacity, utilisation and output of key CCMP and downstream technical producers were assessed and aggregated by country and region. Captive consumption and merchant sales were valued separately and combined to arrive at regional and global totals.
Data triangulation: Estimates from the top-down and bottom-up approaches were reconciled with trade data, company disclosures and primary interview inputs. Where discrepancies arose, assumptions were revisited and validated with industry experts until the estimates converged.
Forecasting Methodology
Forecasts for 2026–2032 were developed by projecting demand for each downstream product and purity grade at country level and aggregating the results to regional and global totals. The factors considered include:
Crop protection demand drivers: planted area, crop mix, pest pressure and farm income in key agricultural economies.
Regulatory outlook for neonicotinoids, including registration reviews, use restrictions and MRL changes.
Substitution dynamics between imidacloprid, acetamiprid and alternative insecticide chemistries.
Capacity additions, plant relocations and environmental compliance in China and India.
Raw material and energy costs, including pyridine bases, chlorine and solvents, and their effect on CCMP pricing.
The forecasting approach combines time-series analysis of historic data with driver-based modelling and expert validation, so that the projections reflect both established trends and anticipated structural changes.
Assumptions and Limitations
Market values are expressed in nominal USD; exchange-rate fluctuations relative to local currencies are not separately modelled.
The regulatory status of imidacloprid and acetamiprid in major markets is assumed to evolve in line with currently published review schedules, without unanticipated global bans during the forecast period.
Captive CCMP consumption is valued at estimated market-equivalent prices, as transfer prices within integrated producers are not publicly disclosed.
Company-level production data are limited for privately held Chinese producers, and estimates for these firms rely on industry interviews and historical capacity disclosures.
The forecasts do not account for extraordinary events such as major plant accidents, abrupt trade restrictions or extreme weather events affecting crop protection demand.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global CCMP market is moderately consolidated. A limited number of vertically integrated Chinese agrochemical groups account for most production, and they convert the majority of their CCMP output captively into imidacloprid and acetamiprid technical. As a result, the merchant market for CCMP is relatively thin, and competition plays out largely at the level of the downstream technical-grade actives. A second tier of private Chinese producers and an emerging group of Indian pyridine-chain manufacturers complete the supply base.
Competition is driven by cost position, feedstock integration, environmental and safety compliance, product purity and the ability to supply consistent quality to registrants in regulated markets. Because CCMP is an undifferentiated intermediate apart from its purity grade, producers with integrated pyridine or cyclopentadiene feedstocks, efficient chlorination technology and downstream technical capacity have a structural advantage. Environmental enforcement in China has also eliminated weaker competitors and favoured producers located in approved chemical parks.
Key Player Positioning
Leaders: Hailir Pesticides and Chemicals Group, Shandong Sino-Agri Union Biotechnology and Jiangsu Changqing Agrochemical are the most directly positioned participants. Hailir, headquartered in Qingdao and listed on the Shanghai Stock Exchange, reports in-house production of the CCMP intermediate used for its imidacloprid and acetamiprid technical and is one of the leading neonicotinoid producers in China; it reported operating revenue of RMB 4.20 billion for FY2025. Sino-Agri Union, which reported revenue of RMB 1.861 billion for FY2025, operates an integrated intermediate-to-formulation chain and states that it produces CCMP at large scale, with an IPO-funded project for 10,000 tonnes per year of CCMP. Changqing, with roots in the Jiangdu Pesticide Factory founded in 1970, operates 3,000 tonnes per year of imidacloprid technical capacity with associated intermediate production and reported revenue of RMB 3.686 billion for FY2025.
Challengers: Nanjing Red Sun, Jiangsu Yangnong Chemical and Jubilant Ingrevia hold strong positions in adjacent parts of the chain. Red Sun, an integrated pyridine-base producer that also manufactures imidacloprid, reported revenue of RMB 3.08 billion for FY2025 and completed a court-approved restructuring in late 2024. Yangnong, part of the Sinochem group, is a major producer of acetamiprid and imidacloprid technical, with revenue of RMB 11.87 billion for FY2025. Jubilant Ingrevia, one of the world's largest producers of pyridine and beta-picoline, reported revenue of INR 4,388 crore for FY2026 and is expanding its agro-intermediate and CDMO activities.
Niche players: Jiangsu Kesheng Group and Hebei Yetian Agrochemical are privately held neonicotinoid producers with significant imidacloprid and acetamiprid capacity. Their revenues are not publicly disclosed. Kesheng has also contributed to published research on CCMP synthesis and applications.
Competitor Dashboard
The dashboard below presents an analyst assessment of the profiled companies across four parameters.
Threat of New Entrants: Low
CCMP production requires specialised chlorination technology, process safety systems and waste-treatment infrastructure, which create high capital and know-how barriers.
Environmental permitting and chemical park approval in China and India are lengthy and increasingly selective.
Established integrated producers benefit from scale, feedstock integration and long-standing customer qualification.
Bargaining Power of Suppliers: Medium
Pyridine and picoline production is concentrated among a limited number of producers in China and India, giving feedstock suppliers some pricing leverage.
Chlorine and common solvents are widely available commodities, which limits supplier power for these inputs.
Integrated producers that make their own pyridine bases reduce their exposure to external suppliers.
Bargaining Power of Buyers: Medium
A large share of CCMP is consumed captively, which limits the pool of merchant buyers but also reduces their negotiating options.
Large technical producers purchase in volume and can switch between qualified suppliers, particularly during periods of oversupply.
Strict purity and impurity requirements raise switching costs once a supplier is qualified.
Threat of Substitutes: Medium
There is no practical substitute intermediate for CCMP in the synthesis of imidacloprid and acetamiprid.
At the end-use level, alternative insecticides such as diamides, sulfoximines, butenolides and pyrethroids compete for the same pests.
Regulatory restrictions on neonicotinoids accelerate substitution in regulated markets, while cost advantages sustain neonicotinoid use in price-sensitive markets.
Competitive Rivalry: High
Numerous Chinese producers compete on cost, and capacity additions periodically lead to oversupply and price competition.
Products are largely undifferentiated beyond purity grade, so price and reliability are the main competitive factors.
Downstream integration and environmental compliance increasingly separate stronger competitors from weaker ones.
Threat of new entrants: Low; High technical, capital and environmental-permitting barriers.
Bargaining power of suppliers: Medium; Concentrated pyridine supply offset by commodity chlorine and integration.
Bargaining power of buyers: Medium; Captive consumption and qualification requirements balance buyer volume leverage.
Threat of substitutes: Medium; No substitute intermediate; competing insecticide chemistries at end-use level.
Competitive rivalry: High; Cost-based competition among Chinese producers and cyclical oversupply.
Market estimates by geography (2032)
InsightAsia Pacific leads with $23.37M by 2032, while Latin America is projected to grow fastest at a 7.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.98M | $1.28M | $1.67M | 5.5% | 6% |
| Europe | $1.32M | $1.69M | $2.15M | 5.0% | 7% |
| Asia Pacific | $12.33M | $17.03M | $23.37M | 6.6% | 79% |
| Latin America | $0.91M | $1.34M | $1.94M | 7.8% | 7% |
| Middle East & Africa | $0.31M | $0.44M | $0.63M | 7.5% | 2% |
| Total | $15.85M | $21.79M | $29.77M | 6.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$29.77M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Imidacloprid | $15.52M | 5.7% | 52% |
| Acetamiprid | $9.59M | 7.6% | 32% |
| Others | $4.65M | 7.2% | 16% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on 2-Chloro-5-Chloromethylpyridine Market covering market dynamics, competitive landscape, and strategic outlook.
The 2-Chloro-5-Chloromethylpyridine Market market is projected to reach $29.77M by 2032, growing at 6.5% CAGR. The Imidacloprid segment holds the largest share.
Demand for CCMP is a derived demand: it follows the production of technical-grade imidacloprid, acetamiprid and other chloronicotinyl insecticides, which in turn follows insecticide consumption in agriculture, horticulture, seed treatment and non-crop uses. The dynamics of the market therefore combine agricultural fundamentals with regulatory, environmental and industrial factors. The impact scores presented in the growth factor analysis below are analyst assessments, rated on a scale of 1 to 10, of each factor's influence on the market in each period.
Sustained Insecticide Demand in Asia Pacific and Latin America
Imidacloprid and acetamiprid remain among the most widely used insecticides in global agriculture because they are systemic, effective against sucking pests such as aphids, whiteflies, planthoppers and jassids, and available at low cost as off-patent generics. Their largest markets are rice, cotton, vegetables, fruit, soybean and sugarcane in Asia Pacific and Latin America, where pest pressure is high and multiple applications per season are common. Rising food demand, the intensification of farming and the growth of high-value horticulture continue to support insecticide volumes in these regions. This demand base underpins the dominance of Asia Pacific, valued at USD 14.978 Million in 2025, and the higher growth rates in Latin America (7.67%) and the Middle East & Africa (7.37%). Because every tonne of imidacloprid or acetamiprid technical requires a corresponding quantity of CCMP, growth in these downstream actives translates directly into demand for the intermediate.
Shift Toward Acetamiprid
Acetamiprid, a cyano-substituted neonicotinoid originally developed by Nippon Soda, has a lower acute toxicity to honeybees than nitro-substituted neonicotinoids such as imidacloprid, clothianidin and thiamethoxam. This has given it a comparatively more durable regulatory position: its approval was renewed in the European Union in 2018, while imidacloprid's outdoor use was restricted under Implementing Regulation (EU) 2018/783 and its approval subsequently expired. Growers and formulators in markets where nitro-substituted neonicotinoids face restrictions have shifted part of their demand toward acetamiprid, which is also widely used in fruit, vegetable and cotton programmes in Asia and Latin America. As a result, Acetamiprid is the fastest-growing downstream product, projected to rise from USD 5.761 Million in 2025 to USD 9.593 Million by 2032 at a CAGR of 7.52%. Since acetamiprid synthesis also begins with CCMP, the shift redistributes demand within the market rather than reducing it.
Backward Integration and Capacity Investment by Insecticide Producers
Leading Chinese neonicotinoid producers have invested in captive CCMP capacity to secure supply, control impurity profiles and capture intermediate margins. Shandong Sino-Agri Union Biotechnology, for example, allocated part of its 2021 IPO proceeds to a project for 10,000 tonnes per year of CCMP and 5,000 tonnes per year of acetamiprid technical, and Hailir Pesticides and Chemicals Group reports in-house production of the CCMP intermediate used for its imidacloprid and acetamiprid. Integrated pyridine producers such as Nanjing Red Sun link their own 3-methylpyridine output to downstream insecticides. In India, Jubilant Ingrevia commissioned a multipurpose agro-active and intermediate plant at Bharuch in March 2024 on its pyridine value chains. This integration improves cost competitiveness, supports consistent high-purity output and encourages continued investment in CCMP capacity across the forecast period.
Rising Quality Requirements for Technical-Grade Actives
Registration authorities and international specifications, including FAO and WHO specifications for pesticide technical materials, define minimum active ingredient content and limits on relevant impurities in technical-grade products. To meet these requirements efficiently, technical producers favour high-purity CCMP, which improves condensation yields, reduces by-products and lowers downstream purification and waste-treatment costs. Export-oriented producers supplying regulated markets face particularly strict impurity profiling during registration. These requirements are reflected in the purity segmentation: the 98% & Above segment accounted for 80.0% of the market in 2025 and is projected to grow at 6.92%, compared with 4.41% for the Below 98% grade. Producers with advanced chlorination control, distillation and crystallisation capabilities are therefore positioned to benefit from this structural upgrade.
Growth in Emerging Agricultural Markets
Latin America, the Middle East & Africa and parts of South and Southeast Asia offer the strongest growth prospects. Latin America is projected to grow at 7.67% and the Middle East & Africa at 7.37% over 2026–2032, while India is projected to grow at 7.79%. Expanding soybean, sugarcane, cotton and horticulture production, together with food security programmes, create sustained demand for cost-effective systemic insecticides, giving CCMP suppliers opportunities to support downstream producers serving these markets.
Cleaner and More Efficient Synthesis Technologies
Investment in process improvements, such as selective chlorination, continuous-flow processing, catalyst optimisation and solvent recovery, offers producers the opportunity to raise yields, reduce waste and lower costs. Producers that can demonstrate a lower environmental footprint and consistent high-purity output are better placed to secure long-term supply agreements with technical producers serving regulated export markets.
Supply-Chain Diversification Toward India and Integrated Pyridine Producers
Agrochemical companies seeking to diversify sourcing beyond a single country have increased interest in Indian manufacturing. Indian pyridine and picoline producers, together with domestic technical manufacturers, can extend into CCMP and downstream neonicotinoids, supported by domestic feedstock availability. The closure of Aurorium's pyridines plant in Indianapolis in 2023, then the only such plant in the Western Hemisphere, further concentrated pyridine supply in Asia and increased the strategic value of integrated pyridine-to-CCMP capability.
Regulatory Restrictions on Neonicotinoids
Concerns over the effects of neonicotinoids on pollinators and aquatic invertebrates have led to restrictions in several major markets. The European Union restricted imidacloprid, clothianidin and thiamethoxam to permanent greenhouses in 2018 and has since lowered MRLs for clothianidin and thiamethoxam on imported products (Regulation (EU) 2023/334, applicable from March 2026) and for acetamiprid on a range of commodities (Regulation (EU) 2025/158). France has banned neonicotinoids, including acetamiprid, and in August 2025 its Constitutional Council struck down a provision that would have allowed acetamiprid to be reintroduced by derogation. Canada's PMRA has cancelled certain imidacloprid uses, Brazil's IBAMA has restricted uses of imidacloprid and thiamethoxam following re-evaluation, and the US EPA continues its registration review of neonicotinoids. These measures limit demand in regulated markets and create uncertainty for exporters.
Environmental and Safety Compliance Costs
CCMP production involves chlorination chemistry, chlorinated by-products and solvent-intensive purification, which generate waste streams that require treatment. In China, tighter enforcement of environmental and work-safety rules, chemical park rectification and plant relocation programmes, including those under the Yangtze River Protection Law, have raised capital and operating costs and periodically constrained output. Smaller producers that cannot meet these standards have exited, while remaining producers have had to invest in waste treatment and process safety. These costs weigh on margins and can cause supply disruptions.
Price Volatility and Oversupply in Generic Agrochemicals
The generic agrochemical industry experienced a pronounced destocking cycle in 2023 and 2024, during which prices for many technical-grade actives, including neonicotinoids, declined sharply from their 2021–2022 peaks. Capacity additions in China during the earlier upcycle contributed to oversupply. Because CCMP pricing tracks downstream technical prices and pyridine-base costs, these cycles compress margins and make investment returns uncertain, particularly for merchant producers without downstream integration.
Feedstock Integration and Route Selection
Producers are increasingly evaluating the cyclopentadiene–acrolein route against beta-picoline chlorination routes based on feedstock availability, cost and waste profiles. Integrated pyridine producers favour picoline-based routes, while established imidacloprid producers continue to rely on the cyclopentadiene route. Route selection is becoming a key factor in cost competitiveness and environmental performance.
Concentration of Supply in Asia
CCMP production is highly concentrated in China, which accounted for USD 8.687 Million of the market in 2025, with India emerging as a second supply base. This concentration creates exposure to Chinese environmental enforcement, energy policy and trade measures, and is prompting downstream buyers to qualify multiple suppliers.
Tightening Residue Limits in Export Markets
MRL reductions in the European Union for clothianidin, thiamethoxam and acetamiprid affect growers that export fruit, vegetables and other produce to Europe, and may encourage these growers to shift away from neonicotinoids in their spray programmes. Monitoring residue limits in key import markets is becoming an essential part of market planning for CCMP-dependent producers.
Resistance Management and Competition from Newer Chemistries
Long-term, intensive use of neonicotinoids has led to resistance in pests such as whiteflies and planthoppers in some regions. Newer insecticide classes, including diamides, sulfoximines and butenolides, compete for the same pest spectrum. Rotation programmes and mixture products help maintain neonicotinoid use, but competition from newer chemistries remains a challenge to long-term volume growth.
The CCMP value chain extends from basic petrochemical and chlor-alkali feedstocks to the farmers and professional users who apply neonicotinoid insecticides. The main stages are described below.
CCMP is regulated both as an industrial chemical intermediate and, indirectly, through the registration of the insecticides made from it. The key regulations and standards in major regions are summarised below.
Jun 2022: Hailir Pesticides and Chemicals Group; Expansion; Started trial production at Phase I of its Qingdao Hengning production base.
2022: Shandong Sino-Agri Union Biotechnology; Expansion; Progressed construction of an IPO-funded project for 10,000 tonnes per year of CCMP and 5,000 tonnes per year of acetamiprid technical, with planned investment of RMB 200 million.
2022: Jiangsu Changqing Agrochemical; Expansion; Began trial production of 3,000 tonnes of thiamethoxam at its Hubei base as part of its relocation and expansion programme.
Dec 2022: Hailir Pesticides and Chemicals Group; Expansion; Started trial production of a 3,000-tonne prothioconazole unit, diversifying beyond neonicotinoids.
Mar 2023: Shandong Sino-Agri Union Biotechnology; Product Launch; Advanced commercialisation of its self-developed insecticide trifluenfuronate.
Mar 2024: Jubilant Ingrevia; Expansion; Commissioned a multipurpose agro-active and intermediate plant at Bharuch, Gujarat, on its pyridine and non-pyridine value chains.
Aug 2024: Hailir Pesticides and Chemicals Group; Expansion; Started trial production of a 2,000-tonne tolfenpyrad unit.
Nov 2024: Nanjing Red Sun; Restructuring; Nanjing court approved its restructuring plan, after which state capital from Qujing, Yunnan, took control of the company.
Dec 2024: Hailir Pesticides and Chemicals Group; Expansion; Started trial production of a 1,500-tonne dinotefuran unit, extending its neonicotinoid portfolio.
Apr 2025: Hailir Pesticides and Chemicals Group; Investment; Announced an RMB 781.87 million project at Hengning that includes pyridine intermediates such as 2,3-dichloropyridine, 2,6-dichloropyridine and 2,3,6-trichloropyridine.
2025: Jiangsu Yangnong Chemical; Expansion; Brought capacity at its Liaoning Youchuang site on stream, with Phase 2 planned for 2026.
2025: Nanjing Red Sun; R&D; Established a Central Research Institute to support process optimisation and new product development.
Nov 2025: Jiangsu Changqing Agrochemical; Expansion; Filed an environmental impact assessment for 4,200 tonnes per year of pyrethroid capacity in Hubei.
FY2026: Jubilant Ingrevia; Expansion; Began dispatches from its new agro CDMO facility, supporting growth in pyridine and derivative products.
Apr 2026: Nanjing Red Sun; Investment; Formed the subsidiary Jiangsu Huazhou Biotech to develop synthetic biology products.
H1 2026: Jiangsu Yangnong Chemical; Expansion; Completed trial production of stage 2 of Phase 1 at Liaoning Youchuang, with Phase 2 in the approval process.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the 2-Chloro-5-Chloromethylpyridine Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the 2-Chloro-5-Chloromethylpyridine Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global 2-Chloro-5-Chloromethylpyridine Market By Purity
Global 2-Chloro-5-Chloromethylpyridine Market By Downstream Product
Global 2-Chloro-5-Chloromethylpyridine Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
